A detailed history of Two Sigma Investments, LP transactions in Moderna, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 627,482 shares of MRNA stock, worth $23.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
627,482
Previous 19,377 3138.28%
Holding current value
$23.1 Million
Previous $2.3 Million 1722.43%
% of portfolio
0.1%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $38.7 Million - $76.1 Million
608,105 Added 3138.28%
627,482 $41.9 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $1.35 Million - $2.02 Million
19,377 New
19,377 $1.93 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $74.3 Million - $101 Million
626,991 Added 3665.11%
644,098 $78.3 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $2.32 Million - $3.37 Million
17,107 New
17,107 $2.63 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $35.9 Million - $66.7 Million
-283,912 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $49.2 Million - $80.3 Million
-217,959 Reduced 43.43%
283,912 $72.1 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $77.9 Million - $170 Million
-350,844 Reduced 41.14%
501,871 $193 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $104 Million - $188 Million
799,228 Added 1494.25%
852,715 $200 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $82.9 Million - $141 Million
-759,077 Reduced 93.42%
53,487 $7 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $53.4 Million - $138 Million
812,564 New
812,564 $84.9 Million
Q3 2019

Nov 14, 2019

SELL
$12.26 - $18.07 $1.51 Million - $2.23 Million
-123,236 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $1.69 Million - $3.49 Million
123,236 New
123,236 $1.8 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.